You searched for metabolic diseases - Page 31 of 63

In Depth 5 May 2023

The biggest private biotech investments in April 2023

…B financing to support phase 1 and 2 trials of its human pluripotent stem cell candidates for lung diseases, degenerative joint diseases, central nervous system (CNS) diseases, and more. Other…

May 5, 2023 - 3 minutesmins - By Willow Shah-Neville

Inflazome Forbion inflammatory disease macrophage

More News! 19 Nov 2018

Anti-Inflammatory Treatments Get €40M Boost in Series B

…factor for many diseases, such as neurodegenerative diseases, autoimmune conditions, and cancer, because it can damage tissue if uncontrolled. One particular inflammasome in Inflazome’s sights is NLRP3. “The NLRP3 inflammasome…

November 19, 2018 - 2 minutesmins - By Jonathan Smith

In Depth 21 Mar 2017

Rethinking Profits: Can a Socially Conscious Model work in Biotech?

…applied to more common diseases. “Whatever we do here, we hope to apply the same tech to diseases that affect more people, like sickle cell anemia and cancer,” says Revah….

March 21, 2017 - 7 minutesmins - By Evelyn Warner

News and Trends 17 Oct 2016

Meet the First Biotech to Jump on Autophagy After This Years’ Nobel Prize

Just after the Nobel Prize was awarded to the study of autophagy, PhoreMost announces a collaboration to target the process in neurodegenerative diseases. PhoreMost is a drug discovery company that…

October 17, 2016 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 12 Oct 2022

Ascidian Therapeutics launches with $50M to rewrite RNA

Ascidian Therapeutics, a biotechnology company focused on treating human diseases by rewriting RNA, has been launched. With an initial focus on replacing mutated exons at the RNA level, Ascidian’s technology…

October 12, 2022 - 4 minutesmins - By Jim Cornall

News and Trends 23 Jun 2023

SandboxAQ launches new division to boost drug development

…diseases are enormously complex and defy standard drug design,” said Stanley B. Prusiner, who leads the UCSF Institute for Neurodegenerative Diseases. “We need rational and structure-based design methods that can…

June 23, 2023 - 3 minutesmins - By Jim Cornall

News and Trends 26 Sep 2022

Everest Medicines gets go-ahead for renal disease drug study

…of EVER001, a next-generation covalent reversible Bruton’s tyrosine kinase (BTK) inhibitor, in development for the treatment of glomerular diseases. The planned phase 1b clinical study will evaluate the safety, efficacy,…

September 26, 2022 - 2 minutesmins - By Jim Cornall

Interview 14 Nov 2022

In depth interview: AstraZeneca/Sanofi RSV drug Beyfortus

…Sanofi answered some questions from Labiotech.eu about the news for our in-depth newsletter on children’s diseases. When it came to finding a solution, what were the steps involved, and how…

November 14, 2022 - 9 minutesmins - By Jim Cornall

News and Trends 8 Mar 2023

The challenges of tackling dementia in women

…comes to addressing women’s health. Dementia is a leading cause of death in women, but it doesn’t get the attention of other diseases, such as breast cancer. Why do you…

March 8, 2023 - 5 minutesmins - By Jim Cornall

News and Trends 1 Mar 2019

Rapid Response mRNA Vaccine Facility Gets €30M Funding

…emerging diseases. CureVac is a company that develops vaccines made of mRNA, a molecule that lets cells translate genes into proteins. The company’s drug candidates deliver mRNA molecules to cells…

March 1, 2019 - 3 minutesmins - By Jonathan Smith

News and Trends 26 Sep 2022

Kupando raises €13M in series A funding round led by Remiges Ventures

…immunity for use in oncology and infectious diseases. Kupando says it will use the funds to complete IND-enabling work and to initiate the clinical development its lead candidate, KUP101 in…

September 26, 2022 - 2 minutesmins - By Liza Laws

Best in Biotech 24 Oct 2024

Six biotech companies advancing multiple sclerosis therapies

…its potential to treat autoimmune disorders, too. This is what Kyverna Therapeutics is focusing on, as it is attempting to develop cell therapies for patients suffering from B-cell-driven autoimmune diseases….

October 24, 2024 - 8 minutesmins - By Willow Shah-Neville

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: metabolic diseases

The biggest private biotech investments in April 2023

Anti-Inflammatory Treatments Get €40M Boost in Series B

Rethinking Profits: Can a Socially Conscious Model work in Biotech?

Meet the First Biotech to Jump on Autophagy After This Years’ Nobel Prize

Ascidian Therapeutics launches with $50M to rewrite RNA

SandboxAQ launches new division to boost drug development

Everest Medicines gets go-ahead for renal disease drug study

In depth interview: AstraZeneca/Sanofi RSV drug Beyfortus

The challenges of tackling dementia in women

Rapid Response mRNA Vaccine Facility Gets €30M Funding

Kupando raises €13M in series A funding round led by Remiges Ventures

Six biotech companies advancing multiple sclerosis therapies

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!